Articles

Obesity in the Elderly – On the Role of Adipokines in Prostate Cancer Progression
Adriano Angelucci, Mauro Bologna
European Oncology & Haematology, 2012;8(1):46-51
Cabazitaxel in the Management of Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel-based Chemotherapy
Axel Heidenreich, David Pfister
European Oncology & Haematology, 2012;8(1):42-45
Docetaxel Rechallenge in Patients with Castration-resistant Prostate Cancer – A Review
Orazio Caffo, Giovanni Pappagallo, Lucianna Maria Russo, Antonello Veccia, Enzo Galligioni
European Oncology & Haematology, 2012;8(1):36-41
Health Status Screening in Elderly Patients – Is this the Way Forward?
Joanna Kazmierska
European Oncology & Haematology, 2012;8(1):63-68
A Review of Sleep Concerns in Paediatric Sickle Cell Disease
Lauren C Daniel, Lamia P Barakat
European Oncology & Haematology, 2012;8(1):58-62
Use of Bendamustine in Chronic Lymphocytic Leukaemia Patients with Co-morbidities
Véronique Leblond
European Oncology & Haematology, 2012;8(1):52-57
VAL 201 – An Inhibitor of Androgen Receptor-associated Src and a Potential Treatment of Castration-resistant Prostate Cancer
Ferdinando Auricchio, Antimo Migliaccio
European Oncology & Haematology, 2012;8(1):32-35
Surgery of the Primary Tumour in Stage IV Colorectal Cancer with Unresectable Metastases
Ninos Ayez, Wijnand J Alberda, Henk M Verheul, Jacobus W Burger, Johannes H de Wilt, Cornelis Verhoef
European Oncology & Haematology, 2012;8(1):27-31
Concurrent Chemoradiation in Inoperable, Locally Advanced Non-small Cell Lung Cancer – Comparison of Efficacy and Toxicity in the Elderly
Christine Collen, Denis Schallier, Mark De Ridder
European Oncology & Haematology, 2012;8(1):24-26
Inflammatory Breast Cancer – Does the Confirmation of Dermal Lymphatic Invasion Predict the Worst Outcome?
Zorica Tomasevic, Daniela Kolarevic
European Oncology & Haematology, 2012;8(1):20-23
The Use of Prophylactic Granulocyte-colony Stimulating Factor for Chemotherapy-induced Febrile Neutropenia
Shiva K Natarajan, Shruthi Narayan, John A Liu Yin, Angela Chan
European Oncology & Haematology, 2012;8(1):14-19
Fifty Years of Progress Against Cancer – The European Organisation for Research and Treatment of Cancer Celebrates its Achievements
John Bean, Denis Lacombe, Dr Françoise Meunier
European Oncology & Haematology, 2012;8(1):10-13
The Role of Imaging in Suspected Prostate Cancer
Adil Ouzzane, Arnauld Villers
European Oncology & Haematology, 2011;7(4):247-250
Dynamics of Human Papillomavirus and Cervical Cancer Screening
Channa E Schmeink, Leon FAG Massuger, Willem JG Melchers, Ruud LM Bekkers
European Oncology & Haematology, 2011;7(4):243-246
Future Role of the Gastroenterologist in Digestive Oncology – A European Perspective
Thomas Seufferlein, Wolff Schmiegel
European Oncology & Haematology, 2011;7(4):240-242
A Review of Targeted Therapies in the Management of Advanced-stage Hepatocellular Carcinoma
Tony Hung, Richard S Finn
European Oncology & Haematology, 2011;7(4):234-239
The End of Cytotoxics?
Nalân Utku
European Oncology & Haematology, 2011;7(4):228-233
Current Epidemiology and Prevention of Infectious Complications in Cancer Patients
Corrado Girmenia, Francesco Menichetti
European Oncology & Haematology, 2011;7(4):270-277
Update on the Management of Febrile Neutropenia
Shiva K Natarajan, Shruthi Narayan, John A Liu Yin
European Oncology & Haematology, 2011;7(4):263-269
Review of Data for Monoclonal Antibody-purified Plasma-derived Factor IX
Massimo Morfini, Wolfhart Kreuz
European Oncology & Haematology, 2011;7(4):257-262
close

This content is copyright protected

However, if you would like to share the information on this webpage, you may use the headline and link below:

Articles

Read more: Articles